Log In
Print
BCIQ
Print
Print this Print this
 

Invega Sustenna paliperidone palmitate

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionIntramuscular injection of paliperidone, a metabolite of risperidone, given once every 3 months
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase III
IndicationSchizophrenia
Partner

Alkermes plc
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today